Published 20 days ago

Pfizer to seek wider use of RSV shot after trial in young adults

Summary by NNY360

Pfizer Inc.’s RSV shot produced immune reactions in young adults at higher risk of severe illness just as well as in older people, spurring the company’s plans to apply for wider U.S. approval.

0 Articles

All

Left

Center

Right

NNY360

Pfizer to seek wider use of RSV shot after trial in young adults

Pfizer Inc.’s RSV shot produced immune reactions in young adults at higher risk of severe illness just as well as in older people, spurring the company’s plans to apply for wider U.S. approval.

20 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated20 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Pfizer to seek wider use of RSV shot after trial in young adults

0 Articles

0 Articles

Pfizer to seek wider use of RSV shot after trial in young adults

Pfizer to seek wider use of RSV shot after trial in young adults

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics